Suppr超能文献

在 1 型先天性肌强直性营养不良中建立通用 CTG 大小测量方法的必要性。

The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1.

机构信息

Neuromuscular and Neuropediatric Research Group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, 08916 Badalona, Barcelona, Spain.

Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.

出版信息

Genes (Basel). 2020 Jul 7;11(7):757. doi: 10.3390/genes11070757.

Abstract

The number of cytosine-thymine-guanine (CTG) repeats ('CTG expansion size') in the 3'untranslated region (UTR) region of the -protein kinase () gene is a hallmark of myotonic dystrophy type 1 (DM1), which has been related to age of disease onset and clinical severity. However, accurate determination of CTG expansion size is challenging due to its characteristic instability. We compared five different approaches (heat pulse extension polymerase chain reaction [PCR], long PCR-Southern blot [with three different primers sets-1, 2 and 3] and small pool [SP]-PCR) to estimate CTG expansion size in the progenitor allele as well as the most abundant CTG expansion size, in 15 patients with DM1. Our results indicated variability between the methods (although we found no overall differences between long PCR 1 and 2 and SP-PCR, respectively). While keeping in mind the limited sample size of our patient cohort, SP-PCR appeared as the most suitable technique, with an inverse significant correlation found between CTG expansion size of the progenitor allele, as determined by this method, and age of disease onset (r = -0.734, = 0.016). Yet, in light of the variability of the results obtained with the different methods, we propose that an international agreement is needed to determine which is the most suitable method for assessing CTG expansion size in DM1.

摘要

肌强直性营养不良 1 型(DM1)的特征是 -蛋白激酶(PKM2)基因 3'非翻译区(UTR)区域中的胞嘧啶-胸腺嘧啶-鸟嘌呤(CTG)重复数(“CTG 扩展大小”),与疾病发病年龄和临床严重程度有关。然而,由于其特征不稳定性,准确确定 CTG 扩展大小具有挑战性。我们比较了五种不同的方法(热脉冲延伸聚合酶链反应(PCR)、长 PCR- Southern 印迹(使用三个不同的引物组-1、2 和 3)和小池(SP)-PCR),以估计 15 名 DM1 患者的前体等位基因和最丰富的 CTG 扩展大小的 CTG 扩展大小。我们的结果表明,这些方法之间存在可变性(尽管我们没有发现长 PCR1 和 2 与 SP-PCR 之间存在总体差异)。虽然考虑到我们患者队列的样本量有限,但 SP-PCR 似乎是最合适的技术,通过该方法确定的前体等位基因 CTG 扩展大小与疾病发病年龄呈显著负相关(r=-0.734,=0.016)。然而,鉴于不同方法获得的结果存在可变性,我们建议需要达成国际协议,以确定评估 DM1 中 CTG 扩展大小的最适合方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88d4/7397178/cb1e7d3f583d/genes-11-00757-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验